Deep Creek Pharma LLC

Yadkinville, NC

UEI
K3KKUWLAKDE3
CAGE
8G9W4
Primary NAICS
541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Self Certified Small Disadvantaged Business
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Similar vendors

About the company

Deep Creek Pharma LLC is a small disadvantaged business located in Yadkinville, North Carolina, registered in SAM.gov since December 20, 2019, with registration valid through March 27, 2026. As a for-profit corporate entity, the company appears to specialize in developing innovative pharmaceutical and therapeutic solutions, with a primary focus on cancer treatment research. Their work primarily involves advanced nanoscale material development and molecular engineering targeting cancer treatment, particularly colorectal cancer therapies.

The company has received multiple project grants from the National Cancer Institute (CFDA 93.395 - Cancer Treatment Research), focusing on developing novel therapeutic approaches for metastatic colorectal cancer. Their research has centered on two primary innovations: TBAEFPREX, a modified thrombin-binding aptamer designed to target cancer cells with high cytotoxicity, and CF10, a DNA-based fluoropyrimidine polymer that demonstrates improved potency and reduced systemic toxicity compared to traditional 5-fluorouracil (5-FU) treatments. Deep Creek Pharma collaborates closely with Wake Forest University Health Sciences and Wake Forest School of Medicine, leveraging academic partnerships to advance their research. Their grant-funded projects have explored developing lipid nanoparticle formulations, investigating anti-metastatic activities in various colon tumor models, and creating more effective treatment strategies for patients with metastatic colorectal cancer that is resistant to conventional therapies.

Quick answers

Is Deep Creek Pharma LLC registered in SAM.gov?

Yes. Deep Creek Pharma LLC's SAM.gov registration is active through June 18, 2027.

What is Deep Creek Pharma LLC's CAGE code?

Deep Creek Pharma LLC's CAGE code is 8G9W4, and its Unique Entity ID (UEI) is K3KKUWLAKDE3.

What is Deep Creek Pharma LLC's most recent federal award?

Deep Creek Pharma LLC's most recent federal grant award is Modified thrombin binding aptamer treatment of CRC metastasis (R41CA302074), from National Cancer Institute (NIH), on September 2, 2025.

On GovTribe

See Deep Creek Pharma LLC's full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors

Find teaming partners on GovTribe